Karine Barral

Title: Karine Barral: Innovator in Antiviral Compounds

Introduction

Karine Barral is a notable inventor based in Marseilles, France. She has made significant contributions to the field of antiviral research through her innovative work on nucleotide analogues. Her inventions focus on developing compounds that can serve as precursors for antiviral medications.

Latest Patents

Karine Barral holds a patent for "Nucleotide analogues as precursor molecules for antivirals." This invention pertains to a purine or pyrimidine phosphonate compound, which can be utilized as antiviral precursors. The patent outlines therapeutic compositions of these compounds and their application in preparing medications for testing and preventing viral infections in patients. Additionally, it provides methods for synthesizing these compounds, particularly highlighting an H-phosphinate precursor intermediate.

Career Highlights

Throughout her career, Karine Barral has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université d'Aix-Marseille. Her research has significantly advanced the understanding of antiviral therapies and their development.

Collaborations

Karine has collaborated with notable colleagues, including Bruno Canard and Karine Alvarez. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Karine Barral's work in the field of antiviral compounds showcases her dedication to advancing medical science. Her innovative inventions and collaborations highlight her significant impact on the development of antiviral therapies.